发明名称 Reducing the immunogenicity of fusion proteins
摘要 Disclosed are compositions and methods for producing fusion proteins with reduced immunogenicity. Fusion proteins of the invention include a junction region having an amino acid change that reduces the ability of a junctional epitope to bind to MHC Class II, thereby reducing its interaction with a T-cell receptor. Methods of the invention involve analyzing, changing, or modifying one or more amino acids in the junction region of a fusion protein in order to identify a T-cell epitope and reduce its ability to interact with a T cell receptor. Compositions and methods of the invention are useful in therapy.
申请公布号 US7973150(B2) 申请公布日期 2011.07.05
申请号 US20090552076 申请日期 2009.09.01
申请人 MERCK PATENT GMBH 发明人 GILLIES STEPHEN D.;WAY JEFFREY;HAMILTON ANITA A.
分类号 C07H21/04;C12N15/09;A61K38/00;A61K38/22;A61K38/24;A61K38/27;A61K45/00;A61K47/00;C07K1/00;C07K14/00;C07K14/505;C07K14/52;C07K14/54;C07K14/55;C07K14/575;C07K14/705;C07K14/725;C07K14/76;C07K16/00;C07K16/18;C07K17/00;C07K19/00;C12N15/62;G01N33/53 主分类号 C07H21/04
代理机构 代理人
主权项
地址